AG
FURX

Artal Group’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Artal Group’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-100,000
Closed -$10.6M – 102
2014
Q2 		$10.6M Hold
100,000
– – 0.43% 46
2014
Q1 		$8.7M Buy
+100,000
New +$7.72M 0.31% 58

Artal Group's FURX Position: Q2 2014 in Review

Artal Group sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q2 2014, closing a stake of 798,900 shares — an estimated $78.4M sold.

Artal Group first reported a position in FURX in Q2 2013 and held it in 4 quarters. The position peaked at $69.5M in Q1 2014. 102 funds tracked by Wall St. Rank hold FURX as of Q2 2014.

  • Artal Group reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • Artal Group sold 798,900 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2014, an estimated $78.4M.
  • Artal Group first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 4 quarters.
  • Artal Group's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $69.5M in Q1 2014.
  • 102 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2014.

Based on Artal Group's 13F filing for Q2 2014, filed 14 Aug 2014.